Vela Technologies #VELA – Put Option for potential sale of Economic Interest in AZD1656 April 20, 2023 – Posted in: Blog, Vela Technologies Plc (VELA)

The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, is pleased to announce that the Company has today entered into a put option agreement (“the Option Agreement”) to give the Company the right, but not the obligation (“the Option”), to sell its economic interest in the commercialisation of the Covid-19 application of AZD1656 for a total consideration of £4.0 million. The Option is being granted by…

Continue reading

#VELA TECHNOLOGIES PLC – PUT OPTION AGREEMENT – COVID-19 application of AZD1656 – Posted in: Blog, Vela Technologies Plc (VELA)

Put Option for potential sale of Economic Interest in AZD1656 The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, is pleased to announce that the Company has today entered into a put option agreement (“the Option Agreement”) to give the Company the right, but not the obligation (“the Option”), to sell its economic interest in the commercialisation of the Covid-19 application of AZD1656 for a total…

Continue reading

Vela Technologies #VELA – Update re. AZD1656 November 9, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, notes the announcement made yesterday evening by Conduit Pharmaceuticals Limited (“Conduit”) that it intends to become a publicly traded company on NASDAQ in the USA via a merger with Murphy Cannon Acquisition Corp. (“Murphy”), a NASDAQ-listed special purpose acquisition company. Vela holds an economic interest in the commercialisation of a particular application of AZD1656, one of the…

Continue reading